SPONSORED

Texas: Delta-8 cannabis extract is illegal

Shock wave goes through CBD retail industry

•• 4 Min
Texas: Delta-8 cannabis extract is illegal

Three years after federal law removed the marijuana extract known as Delta-8 THC from the national controlled substances list, Texas health officials put it on their own list of illicit drugs, sending a shockwave through the growing CBD retail industry across the state and basically made the substance illegal.

Christine Perez, who runs the popular CBD store Lazydaze + Coffeeshop in Austin, had no idea of ​​the change until she saw the notice from the Texas Department of State Health Services on the agency's website on Oct.15.

"I was very confused, as have a number of other companies. I was like, 'What's going on here?'" Said Perez. "I really have no idea why [the state] would try to ban it, or when to do it. We haven't heard from the state about it."

It was easy to miss.

As reported by the Dallas Morning News earlier this week, the state health department posted a notice in its rule change publication, the Texas Register. It said that Delta-8 was still a controlled drug in Texas. Both the federal government and states can keep different lists of what a controlled substance is. Still, the CBD stores have not been told that it is illegal to sell products containing the substance, such as candy or tinctures, in Texas.

The CBD oil has become a top product for many Texas pharmacies as users say it creates the "high" effect of marijuana. The variant became popular after the 2018 Agriculture Act changed the definition of "legal marijuana extracts" to include any extract that contains less than 0.3% tetrahydrocannabinol (THC), including Delta-8. THC is the active psychoactive ingredient in marijuana that is responsible for the high in the user.

Almost two years ago Delta-8 was thought to be legal in Texas after Governor Greg Abbott signed House Bill 1325, which legalizes any hemp product with less than 0.3% THC.

But last week the DSHS announced that it had classified Delta-8 as a List I controlled substance, a category reserved for drugs with no recognized medical use such as heroin and LSD.

It is not the first time this debate has arisen over whether or not Delta-8 is a controlled substance in Texas. As DMN previously reported, Stephen Pahl, the Texas Department of Health's deputy consumer protection commissioner, informed lawmakers during this year's regular term that state law allows DSHS commissioner John Hellerstedt to object to federal drug lists, including Delta-8 . Legislators had considered a bill to make Delta-8 illegal, but it failed after health officials informed them that it had already been listed as a controlled substance by the state.

From the government's point of view, last week's announcement was merely a clarification.

"The DSHS has posted the following clarification on our website in response to recent inquiries from hemp growers who said there is confusion in the industry about what is allowed in consumable hemp products," said Lara Anton, a spokeswoman for the DSHS.

However, to retailers, the notice appeared arbitrary and unfair.

"This really comes out of the blue. It is not based on science or any real threat to Texans," said Rick Trojan III, a board member of the Hemp Industries Association. "The whole thing is confusing for everyone involved. It sounds like the DSHS doesn't even understand why they know what they are doing."

Trojan said he hadn't heard a "cannabis grower" confused about the law.

As of this announcement a week ago, several businesses claimed the state had done nothing to inform them that Delta-8 was illegal.

Lit Smoke & Vape, a CBD store in Allen, says it won't stop selling Delta-8 until forced to do so.

Other stores, like Your CBD in Mesquite, were unaware of the new guidelines when asked by the Texas Tribune. An hour later, the company took Delta-8 off the shelves.

"It's still on our shelves until a legal decision is made that it's illegal," said a manager at Lit Smoke & Vape. “These people have no authority over the law. So unless the law says it's illegal, we'll keep selling it. Two years ago they tried to ban CBD and they were sued and it failed. It so will happen again. "

In May last year, the Texas legislature tried to ban Delta-8, but failed.

Several companies, including CBD American Shaman, have announced legal action against the state.

In the meantime, many companies are wondering how the state will enforce the new guidelines.

"The DSHS can take enforcement action against licensees who sell consumable hemp products that contain controlled substances. The DSHS does not regulate the possession of controlled substances," said a DSHS spokesman.

However, Trojan believes that enforcement will be difficult.

"I heard that some sheriffs will not enforce the rules. I heard that the stores can sell what they have," Trojan said.

TexasMarijuana CBD

Most Popular News

  1. SpaceX’s $8B Spectrum Deal Sends AT&T, Verizon, and T-Mobile Plummeting
  2. Is Project Vault Securing America’s Supply Chain or Squeezing It to the Breaking Point?
  3. Why Gautam Lohia Shifted from Global Consulting to Reboot a $20M Tech Micro-Cap
  4. Everyday Luxury, Unstoppable Scale: Aritzia Delivers 44% Net Revenue Growth
  5. Can Navy SEAL Leadership and Big Tech Scale Revolutionize Airborne Threat Detection?

Disclaimer


This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.